Eric G. Carter

Insider Reports History

Location
Bristol, TN
Signature
/s/ Alexander Wilson, as attorney-in-fact for Eric G. Carter
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Eric G. Carter:

Stock Role Class Num Shares Value Price $ Report Date Ownership
AEON Biopharma, Inc. Director Restricted Stock Units 309K 21 May 2025 Direct
AEON Biopharma, Inc. Director Stock Option 96.2K 31 Aug 2024 Direct
AEON Biopharma, Inc. Director Class A Common Stock 36K 31 Aug 2024 Direct

Insider Reports Filed by Eric G. Carter

Symbol Company Period Transactions Value $ Form Type Role Filing Time
AEON AEON Biopharma, Inc. 21 May 2025 1 $0 4 Director 23 May 2025, 16:50
AEON AEON Biopharma, Inc. 31 Aug 2024 2 $0 4 Director 04 Sep 2024, 21:52
AEON AEON Biopharma, Inc. 19 Mar 2024 2 $0 4 Director 21 Mar 2024, 19:45
AEON AEON Biopharma, Inc. 14 Aug 2023 1 $0 4 Director 16 Aug 2023, 17:05
AEON AEON Biopharma, Inc. 21 Jul 2023 2 $0 4 Director 24 Jul 2023, 21:09
AEON AEON Biopharma, Inc. 21 Jul 2023 0 $0 3 Director 24 Jul 2023, 21:02